SBC

SBC Medical GroupD

Nasdaq / Health Care Equipment & Services

At close

2026-06-02

Current thesis

The constructive case is balance-sheet-backed optionality: SBC ended 2025 with substantial cash, no immediate stated liquidity gap, and an authorized buyback that could become a signaling tool if management starts using it meaningfully. [#10-K-2026-03-27]

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.1.

What can break

Disclosure controls were not effective as of December 31, 2025 because material weaknesses in internal control over financial reporting had not been fully remediated. [#10-K-2026-03-27]

Momentum

Value

Sentiment

Setup hits (3d)

0 · Net Neutral

AI TargetsBase $3.10 · Bull $4.60 · Bear $2.10

Data freshness

Prices

As of 2026-06-02

Fundamentals

As of 2026-06-02 • Vendor: Data Vendor v1

Scores

As of 2026-06-02 • Model: HYBRID_IC_RP

AI Memo

As of 2026-05-05 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-06-02

Supporting evidence

What

Grade D · Defensive

Confidence Medium · Net Neutral

Target $8.17

Why

Momentum21 · Δ7d -

Value56 · Δ7d -0.1

Sentiment44 · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Lead driver: Value · See fundamentals

Momentum

34% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

32% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

+0.2

Sentiment

33% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade D. Momentum 20.6 / Value 56.4 / Sentiment 44.5

Fundamentals (TTM)

As of 2026-06-02

Market Cap

$329.11M

Beta

1.13

Shares Out

102.58M

P/E (TTM)

10.7

P/S (TTM)

2.59

P/FCF (TTM)

26.88

Rev YoY

-18.3%

EPS YoY

+319.4%

Gross Margin

+74.1%

Op Margin

+38.2%

Net Debt

-$118.41M

Current Ratio

5.10

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology